Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients
Open Access
- 1 January 2020
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 28, e3304
Abstract
Objective: to analyze the evidence available in the literature about the lowest necessary dose of heparin to maintain the patency of the totally implanted central venous catheter in adult cancer patients. Method: an integrative literature review, carried out in the following databases: Literatura Latino-Americana e do Caribe em Ciências de Saúde, Sciverse Scopus, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, including thirteen studies. Results: the evidence showed that the dose of heparin (300 IU/ml) is the most used in maintaining the patency of the totally implanted central venous catheter. Conclusion: according to the selected studies, the lowest dose of heparin found in maintaining the patency of the totally implanted central venous catheter in cancer patients was 10 UN/ml with a volume of 5 ml of the heparin solution.Keywords
This publication has 29 references indexed in Scilit:
- Effect of port-care frequency on venous port catheter-related complications in cancer patientsInternational Journal of Clinical Oncology, 2013
- Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2013
- Efficacy of Normal Saline Versus Heparinized Saline Solution for Locking Catheters of Totally Implantable Long-Term Central Vascular Access Devices in Adult Cancer PatientsCancer Nursing, 2012
- Heparin or 0.9% sodium chloride to maintain central venous catheter patencyCritical Care Medicine, 2012
- The methodological quality of systematic reviews of animal studies in dentistryThe Veterinary Journal, 2012
- ESPEN Guidelines on Parenteral Nutrition: Central Venous Catheters (access, care, diagnosis and therapy of complications)Clinical Nutrition, 2009
- Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancerEuropean Journal of Cancer Care, 2009
- The integrative review: updated methodologyJournal of Advanced Nursing, 2005
- How Often Should a Port-A-Cath be Flushed?Cancer Investigation, 2005
- Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia?a randomized studySupportive Care in Cancer, 2004